Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GQ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,950
Award facts
- Contract value 100% obligated
- $14,949.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,949.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Cencora, Inc.) on January 26, 2026, for the supply of XELJANZ XR 11 mg tablets in quantities of 30-count units. This non-set-aside, competitively awarded contract has an ultimate completion date of January 27, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains extensive federal contract experience with DLA and the Department of Veterans Affairs, consistently delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across diverse therapeutic categories including diabetes, neurology, pain management, and oncology through firm fixed-price delivery orders and purchase orders.
Quick answers
Who was awarded contract SPE2DR26F4GQ7?
SPE2DR26F4GQ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F4GQ7 worth?
The government has obligated $14,950 on SPE2DR26F4GQ7.
Is contract SPE2DR26F4GQ7 an order under another contract?
Yes. SPE2DR26F4GQ7 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GQ7 competed?
The extent of competition for SPE2DR26F4GQ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award